KNOTT, Verner J
$227,725.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2014-2015
Canada
A Proof-of-Concept Phase-I Trial of an Alpha7 Nicotinic Agonist for Cognitive Deficits in Schizophrenia